Age Trends in Growth and Differentiation Factor-11 and Myostatin Levels in Healthy Men, and Differential Response to Testosterone, Measured Using Liquid Chromatography-Tandem Mass Spectrometry.
Aging
Androgen
Antigeronic factors
BMP-11
Myostatin
Journal
The journals of gerontology. Series A, Biological sciences and medical sciences
ISSN: 1758-535X
Titre abrégé: J Gerontol A Biol Sci Med Sci
Pays: United States
ID NLM: 9502837
Informations de publication
Date de publication:
01 04 2022
01 04 2022
Historique:
received:
01
03
2021
pubmed:
27
5
2021
medline:
6
4
2022
entrez:
26
5
2021
Statut:
ppublish
Résumé
Growth and differentiation factor (GDF)-11 controls embryonic development and has been proposed as an antiaging factor. GDF-8 (myostatin) inhibits skeletal muscle growth. Difficulties in accurately measuring circulating GDF-11 and GDF-8 have generated controversy. We developed a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for simultaneous measurement of circulating GDF-8 and GDF-11 that employs denaturation, reduction, and alkylation; cation-exchange solid-phase extraction; tryptic digestion; followed by separation and quantification using 2 signature peptides for multiple reaction monitoring and C-terminal [13C615N4]-Arg peptides as internal standards. We evaluated age trends in serum GDF-11 and GDF-8 concentrations in community-dwelling healthy men, 19 years or older, and determined the effects of graded testosterone doses on GDF-8 and GDF-11 concentrations in healthy men in a randomized trial. The assay demonstrated linearity over a wide range, lower limit of quantitation 0.5 ng/mL for both proteins, and excellent precision, accuracy, and specificity (no detectable cross-reactivity of GDF-8 in GDF-11 assay or of GDF-11 in GDF-8 assay). Mean ± SD (median ± 1QR) GDF-8 and GDF-11 levels in healthy community-dwelling men, 19 years and older, were 7.2 ± 1.9 (6.8 ± 1.4) ng/mL. Neither GDF-8 nor GDF-11 levels were related to age or body composition. Testosterone treatment significantly increased serum GDF-8 but not GDF-11 levels. The LC-MS/MS method for the simultaneous measurement of circulating total GDF-8 and GDF-11 demonstrates the characteristics of a valid assay. Testosterone treatment increased GDF-8 levels, but not GDF-11. Increase in GDF-8 levels by testosterone treatment, which increased muscle mass, suggests that GDF-8 acts as a chalone to restrain muscle growth.
Sections du résumé
BACKGROUND
Growth and differentiation factor (GDF)-11 controls embryonic development and has been proposed as an antiaging factor. GDF-8 (myostatin) inhibits skeletal muscle growth. Difficulties in accurately measuring circulating GDF-11 and GDF-8 have generated controversy.
METHODS
We developed a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for simultaneous measurement of circulating GDF-8 and GDF-11 that employs denaturation, reduction, and alkylation; cation-exchange solid-phase extraction; tryptic digestion; followed by separation and quantification using 2 signature peptides for multiple reaction monitoring and C-terminal [13C615N4]-Arg peptides as internal standards. We evaluated age trends in serum GDF-11 and GDF-8 concentrations in community-dwelling healthy men, 19 years or older, and determined the effects of graded testosterone doses on GDF-8 and GDF-11 concentrations in healthy men in a randomized trial.
RESULTS
The assay demonstrated linearity over a wide range, lower limit of quantitation 0.5 ng/mL for both proteins, and excellent precision, accuracy, and specificity (no detectable cross-reactivity of GDF-8 in GDF-11 assay or of GDF-11 in GDF-8 assay). Mean ± SD (median ± 1QR) GDF-8 and GDF-11 levels in healthy community-dwelling men, 19 years and older, were 7.2 ± 1.9 (6.8 ± 1.4) ng/mL. Neither GDF-8 nor GDF-11 levels were related to age or body composition. Testosterone treatment significantly increased serum GDF-8 but not GDF-11 levels.
CONCLUSIONS
The LC-MS/MS method for the simultaneous measurement of circulating total GDF-8 and GDF-11 demonstrates the characteristics of a valid assay. Testosterone treatment increased GDF-8 levels, but not GDF-11. Increase in GDF-8 levels by testosterone treatment, which increased muscle mass, suggests that GDF-8 acts as a chalone to restrain muscle growth.
Identifiants
pubmed: 34037752
pii: 6284042
doi: 10.1093/gerona/glab146
pmc: PMC8974345
doi:
Substances chimiques
Growth Differentiation Factors
0
Myostatin
0
Testosterone
3XMK78S47O
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
763-769Subventions
Organisme : NIA NIH HHS
ID : R01 AG052964
Pays : United States
Organisme : SBIR
ID : R44G045011
Organisme : NIA NIH HHS
ID : R56 AG052972
Pays : United States
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
Basic Res Cardiol. 2017 Sep;112(5):53
pubmed: 28721633
J Alzheimers Dis. 2018;62(2):807-819
pubmed: 29480172
Science. 2014 May 9;344(6184):649-52
pubmed: 24797481
Cell. 2013 May 9;153(4):828-39
pubmed: 23663781
Clin Chem. 2008 Nov;54(11):1855-63
pubmed: 18801940
Cell. 2010 Aug 20;142(4):531-43
pubmed: 20723755
J Gerontol A Biol Sci Med Sci. 2019 Jan 1;74(1):129-136
pubmed: 30380014
Mol Cell Endocrinol. 2012 Mar 5;350(1):39-52
pubmed: 22138414
Curr Opin Support Palliat Care. 2013 Dec;7(4):352-60
pubmed: 24157714
Am J Physiol Cell Physiol. 2009 Jun;296(6):C1258-70
pubmed: 19357233
FASEB J. 2015 Apr;29(4):1165-75
pubmed: 25466897
Steroids. 2009 Jun;74(6):512-9
pubmed: 19321131
Cell Metab. 2016 Jun 14;23(6):1207-1215
pubmed: 27304512
Annu Rev Cell Dev Biol. 2004;20:61-86
pubmed: 15473835
Am J Clin Nutr. 2002 Aug;76(2):378-83
pubmed: 12145010
Cardiovasc Res. 2005 Dec 1;68(3):347-9
pubmed: 16226233
JAMA. 2012 Mar 7;307(9):931-9
pubmed: 22396515
Circ Res. 2015 Nov 6;117(11):926-32
pubmed: 26383970
Circ Res. 2016 Apr 1;118(7):1125-41; discussion 1142
pubmed: 27034275
Dev Biol. 2004 Jun 1;270(1):19-30
pubmed: 15136138
Mech Dev. 2010 Sep-Dec;127(9-12):485-95
pubmed: 20807570
Cell Metab. 2015 Jul 7;22(1):164-74
pubmed: 26001423
N Engl J Med. 2004 Jun 24;350(26):2682-8
pubmed: 15215484
Aging Cell. 2016 Jun;15(3):582-4
pubmed: 27139744
Science. 2014 May 9;344(6184):630-4
pubmed: 24797482
Endocrinology. 2009 Mar;150(3):1259-68
pubmed: 18948405